{
  "actions": [
    {
      "acted_at": "2020-07-02", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-07-02", 
      "action_code": "", 
      "committees": [
        "SSFI"
      ], 
      "references": [
        {
          "reference": "CR S4228", 
          "type": "Sponsor introductory remarks on measure"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s4199-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "B001310", 
      "district": null, 
      "name": "Braun, Mike", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "IN", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "C001075", 
      "district": null, 
      "name": "Cassidy, Bill", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "LA", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "C001035", 
      "district": null, 
      "name": "Collins, Susan M.", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "ME", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "D000618", 
      "district": null, 
      "name": "Daines, Steve", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "MT", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "E000295", 
      "district": null, 
      "name": "Ernst, Joni", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "IA", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "H001079", 
      "district": null, 
      "name": "Hyde-Smith, Cindy", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "MS", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "M001197", 
      "district": null, 
      "name": "McSally, Martha", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "AZ", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "M001153", 
      "district": null, 
      "name": "Murkowski, Lisa", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "AK", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "P000449", 
      "district": null, 
      "name": "Portman, Rob", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-07-02", 
      "state": "OH", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S001198", 
      "district": null, 
      "name": "Sullivan, Dan", 
      "original_cosponsor": false, 
      "sponsored_at": "2020-09-10", 
      "state": "AK", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-07-02", 
  "number": "4199", 
  "official_title": "A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s2543-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s1999-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s1505-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s801-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr5882-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr5281-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr4649-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr4629-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr3029-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr1781-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr1264-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Prescription Drug Pricing Reduction Act of 2020", 
  "sponsor": {
    "bioguide_id": "G000386", 
    "district": null, 
    "name": "Grassley, Chuck", 
    "state": "IA", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-07-02", 
  "subjects": [
    "Accounting and auditing", 
    "Administrative law and regulatory procedures", 
    "Advisory bodies", 
    "Appropriations", 
    "Congressional oversight", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Emergency medical services and trauma care", 
    "Fraud offenses and financial crimes", 
    "Genetics", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care costs and insurance", 
    "Health care coverage and access", 
    "Health care quality", 
    "Health information and medical records", 
    "Health programs administration and funding", 
    "Health technology, devices, supplies", 
    "Home and outpatient care", 
    "Hospital care", 
    "Indian social and development programs", 
    "Infectious and parasitic diseases", 
    "Inflation and prices", 
    "Intergovernmental relations", 
    "Manufacturing", 
    "Medicaid", 
    "Medical ethics", 
    "Medicare", 
    "Minority health", 
    "Poverty and welfare assistance", 
    "Prescription drugs", 
    "Public contracts and procurement", 
    "Public participation and lobbying", 
    "Retail and wholesale trades", 
    "Social work, volunteer service, charitable organizations", 
    "State and local government operations"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2020-07-02T04:00:00Z", 
    "text": "Prescription Drug Pricing Reduction Act of 2020\n\nThis bill alters several programs and requirements relating to the prices of prescription drugs under Medicare and Medicaid.\n\nAmong other things, the bill\n\n requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for certain drugs covered under Medicare for which the average manufacturer price increases faster than inflation; requires drug manufacturers to issue rebates to the CMS for discarded amounts of certain single-dose drugs covered under Medicare, based on information reported by providers; reduces the annual out-of-pocket spending threshold, and eliminates beneficiary cost-sharing above this threshold, under the Medicare prescription drug benefit; requires the CMS to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and increases the maximum rebate payable by drug manufacturers under the Medicaid Drug Rebate Program."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug Pricing Reduction Act of 2020", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug Pricing Reduction Act of 2020", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Prescription Drug Pricing Reduction Act of 2020", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-09-11T05:49:41Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s4199.xml"
}